Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) - Investor Dashboard


➔ Liberty Health Sciences
CSE Ticker: LHS
OTCQX Ticker: LHSIF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada/U.S.
Employees: 75 as of 6/27/18
Established: 2017
CEO: George Scorsis

Liberty Health Sciences – Management Team & Board


George Scorsis – CEO & Director

  • 20+ Years in CPG working with regulated products
  • Former President of Mettrum Health Corp building it to a $430M business prior to its acquisition by Canopy Growth Corp
  • Former President of Red Bull Canada and instrumental in restructuring the organization from a geographical and operational perspective to grow it to a $150M business
  • Former Executive Leader at Bacardi Canada and was fundamental in new product development and launch

Cole Cacciavillani, Chief Agronomist and Cofounder of Aphria

  • 35+ years in the agriculture business
  • Greenhouse industry pioneer
  • First-hand knowledge of Aphria’s greenhouses

Stephanie Kubacki, Vice President of Marketing

  • 18 years in the alcohol beverage industry
  • Former Director of Strategic Partnerships at InsightAction, Inc.

Board of Directors


Vic Neufeld – CEO, Aphria
  • 20+ Years in Pharma
  • Former CEO of Jamieson Laboratories (1993 – 2014)
  • Demonstrated vision, growth & performance
Aaron Serruya – CEO, YogenFrüz
  • Leader in franchises, co-founder and CEO of YogenFrüz
  • Winner of numerous awards for business excellence
  • Will lead the dispensary expansion initiative in Florida and other states where investments are made
John Cervini – Cofounder & VP Infrastructure & Tech, Aphria
  • 20+ Years in Agri-business
  • Fourth generation greenhouse grower
  • Proven growth & expansion track record

Significant Insider Ownership


Aphria:
64.12 million shares

Aaron Serruya, Director:
7.33 million shares and 1.1 million options

John Cervini, Director:
481K shares and 1.2 million options

Vic Neufeld, Director:
280K shares and 1.85 million options

George Scorsis, CEO:
160K shares and 2.15 million options


Visit Liberty Health Sciences Inc.,
at www.libertyhealthsciences.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Liberty Health Sciences, Inc. is a client of NCV Media, LLC. Read our full disclaimer.